Sanofi Winthrop Industrie
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- France
- Registered address
- 30 AVENUE GUSTAVE EIFFEL, Tours, Centre 37100, France (FRA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003282644 · DUNS 571879985
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-01-27
- VAIDrug Quality Assurance2019-10-10
- VAIDrug Quality Assurance2018-06-15
- NAIDrug Quality Assurance2014-06-06
- NAIDrug Quality Assurance2012-03-23
- NAIDrug Quality Assurance2010-04-29
Drugs this plant is listed as making
6 distinct drugs across 10 products name this site in their FDA label.
- clopidogrelSanofi-Aventis U.S. LLC
- DronedaroneSanofi-Aventis U.S. LLC
- eliglustatGenzyme Corporation
- irbesartanSanofi-Aventis U.S. LLC
- irbesartan and hydrochlorothiazideSanofi-Aventis U.S. LLC
- zolpidem tartrateSanofi-Aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.